Reena retweeted
🚨NEW MAJOR GUIDELINE!🚨
Managing blood pressure in patients on dialysis
One of the first of its kind, this unique & comprehensive guideline makes key recommendations for BP targets, treatment & care strategies.
➡️Download now to discover more: ow.ly/pABq50ViWCB
Reena retweeted
Point-of-care summary of core HFrEF GDMT safety across CKD stages/ ESKD from @ruey_hu @KidneyInCVD
#Nephpearls #Cardiorenal
👉 gdmt.org/Contest/ – at Riverside, IL
Reena retweeted
IgA Nephropathy (IgAN) ca. 2024 from @JASN_News #Nephpearls
📌 Pathogenesis (4 hit hypothesis)
📌 Complement Pathway
📌 Trials
👉🏼 pubmed.ncbi.nlm.nih.gov/3777… – at Maywood, IL
Reena retweeted
Early steroid withdrawal and kidney transplant outcomes in first-transplant and retransplant recipients
doi.org/10.1093/ndt/gfae218
Reena retweeted
Exciting to see this shared! Here's the full paper for anyone interested: frontiersin.org/journals/nep…
This Post is from a suspended account. Learn more
Ten tips on immunosuppression in primary membranous nephropathy academic.oup.com/ckj/article…
Immune checkpoint inhibitor-associated nephritis - treatment standard academic.oup.com/ndt/article…
Reena retweeted
New: Either ACEi or ARB therapy protect against kidney failure in those with advanced CKD. Neither therapy provided a death benefit for those with late-stage CKD: ecs.page.link/SWNAD
Reena retweeted
Complement inhibitors ca. 2024 from @Kidney_Int @goKDIGO #Nephpearls
👉 pubmed.ncbi.nlm.nih.gov/3884…
Reena retweeted
💡ACTUALIZACIÓN @goKDIGO 2024 Clinical Practice Guideline for Antineutrophilic Cytoplasmic Antibody (ANCA)-associated Vasculitis:
🚀kdigo.org/wp-content/uploads…
🚀kdigo.org/guidelines/antineu…
Reena retweeted
Wow
Minimal change disease RIP
Roughly half (higher in kids?) = anti nephrin podocytopathy
Multicentre study validating @AstridWeins et al findings at #ERA24 in @NEJM
nejm.org/doi/full/10.1056/NE…
Reena retweeted
Presented at #ERA24:
FLOW trial: In patients with type 2 diabetes and chronic kidney disease, weekly semaglutide significantly reduced risks of major kidney events, cardiovascular events, and death from any cause while slowing loss of kidney function. nej.md/44U3slP
ALT Graphs showing the first major kidney disease event
Reena retweeted
Lipid management in CKD from @goKDIGO
#NephJC #Nephpearls
#VisualGraphic by @VamsidharV17
👉kdigo.org/guidelines/ckd-eva…
Reena retweeted
Two recent reviews of #ANCA vasculitis with wonderful graphics, and for the first time I think, #PR3🔹 and #MPO🔸 phenotypes are considered in parallel but SEPARATELY! A new era with individualized treatment is coming for sure!
🔹doi.org/10.1016/s2665-9913(2…
🔸doi.org/10.1016/s2665-9913(2…
Reena retweeted
✅ It is my IMMENSE PLEASURE to share with you our SEMINAR on systemic #Lupus just published in... The LANCET!!!!! Amazing work driven by @alberta_hoi 👍
LINK: authors.elsevier.com/a/1ixq7…
Reena retweeted
Updated Review of Membranous Nephropathy ca. 2024 from @indianjnephrol @OrhanEfe_ @nikkonephro @AnandhUrmila @NWiegley @GlomCon #Nephpearls
👉🏼 indianjnephrol.org/an-update… – at Maywood, IL
Reena retweeted
"🔍 Renal biopsy in pregnancy: a challenging yet 💥 sometimes crucial procedure.
⚡️Check out the indications, procedure, and potential complications in my latest infographic.
💫Understanding the delicate balance is key for maternal and fetal health. #RenalBiopsy #PregnancyComplications #Infographic"
Diabetic Nephropathy: Update on Pillars of Therapy Slowing Progression diabetesjournals.org/care/ar…
Reena retweeted
Finally. We figured out the dense deposits in dense deposit disease (DDD).
The answer is Apolipoprotein E.
You can stain for APOE & make the diagnosis of DDD in >80% cases. Without electron 🔬.
DDD was the reason I got into mass spectrometry 17 yrs ago. doi.org/10.1016/j.kint.2024.…